PRESS RELEASE published on 12/20/2023 at 12:45, 11 months 1 day ago MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials
PRESS RELEASE published on 11/21/2023 at 14:42, 1 year ago MindBio Therapeutics Team Members Honoured with Industry Leading Awards
PRESS RELEASE published on 10/31/2023 at 07:30, 1 year ago MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients
PRESS RELEASE published on 10/29/2023 at 03:00, 1 year ago MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
PRESS RELEASE published on 10/26/2023 at 14:50, 1 year ago Mindbio Therapeutics Nominated for Company of the Year in Industry Awards
PRESS RELEASE published on 10/24/2023 at 13:25, 1 year ago MindBio Therapeutics CEO Provides Video Update on Phase 2a Depression Trial Using MB22001
PRESS RELEASE published on 10/05/2023 at 11:29, 1 year 1 month ago Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
PRESS RELEASE published on 09/14/2023 at 15:45, 1 year 2 months ago Mindbio Therapeutics CEO Provides Update on Depression Trial & Novel Discoveries in Psychedelics Research
PRESS RELEASE published on 09/05/2023 at 11:50, 1 year 2 months ago MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
PRESS RELEASE published on 08/24/2023 at 08:30, 1 year 2 months ago Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression
Published on 11/21/2024 at 17:35, 20 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 25 minutes ago SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 25 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 54 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 55 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 15:41, 2 hours 13 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 31 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 10 hours 57 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 35 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
